Apeptico Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
2ndary - Private
Apeptico General Information
Description
Operator of a biotechnology company intended to target and treat chronic and life-threatening diseases. The company's peptide-based products concentrate on synthetically produced protein structures to avoid general risks associated with gene and cell technologies, enabling doctors to reduce treatment costs and shorten the therapy and treatment process.
Contact Information
Website
www.apeptico.comCorporate Office
- Mariahilfer Straße 136
- Top 1.15
- Vienna, 1150
- Austria
Corporate Office
- Mariahilfer Straße 136
- Top 1.15
- Vienna, 1150
- Austria
Apeptico Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 6. Grant | 01-Apr-2020 | Completed | Clinical Trials - Phase 2 | |||
| 5. Grant | 08-Jul-2013 | Completed | Clinical Trials - Phase 2 | |||
| 4. Early Stage VC | 16-May-2012 | Completed | Startup | |||
| 3. Early Stage VC (Series A) | 05-Aug-2010 | Completed | Startup | |||
| 2. Seed Round | 29-May-2009 | $1.37M | $1.37M | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2008 | $2.91K | $2.91K | Completed | Startup |
Apeptico Comparisons
Industry
Financing
Details
Apeptico Competitors (75)
One of Apeptico’s 75 competitors is Spruce Biosciences, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Spruce Biosciences | Formerly VC-backed | South San Francisco, CA | ||||
| NewAmsterdam Pharma | Formerly VC-backed | Aventura, FL | ||||
| Inovio Pharmaceuticals | Corporation | Plymouth Meeting, PA | ||||
| MBX Biosciences | Formerly VC-backed | Carmel, IN | ||||
| PepGen | Formerly VC-backed | Boston, MA |
Apeptico Patents
Apeptico Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4051307-A1 | Peptide for prevention or treatment of covid-19 | Active | 08-May-2020 | ||
| EP-4051307-B1 | Peptide for prevention or treatment of covid-19 | Active | 08-May-2020 | ||
| US-20250241978-A1 | Peptide for prevention or treatment of covid-19 | Pending | 08-May-2020 | ||
| WO-2021223894-A1 | Peptide for prevention or treatment of covid-19 | Inactive | 08-May-2020 | ||
| ES-2938574-T3 | Peptide for the prevention or treatment of covid-19 | Active | 08-May-2020 | A61K38/10 |
Apeptico Signals
Apeptico FAQs
-
When was Apeptico founded?
Apeptico was founded in 2008.
-
Where is Apeptico headquartered?
Apeptico is headquartered in Vienna, Austria.
-
What is the size of Apeptico?
Apeptico has 3 total employees.
-
What industry is Apeptico in?
Apeptico’s primary industry is Drug Discovery.
-
Is Apeptico a private or public company?
Apeptico is a Private company.
-
What is Apeptico’s current revenue?
The current revenue for Apeptico is .
-
How much funding has Apeptico raised over time?
Apeptico has raised $9.7M.
-
Who are Apeptico’s competitors?
Spruce Biosciences, NewAmsterdam Pharma, Inovio Pharmaceuticals, MBX Biosciences, and PepGen are some of the 75 competitors of Apeptico.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process